Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomized, controlled, phase 2b trial.

Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non–Small-Cell Lung Cancer: The Phase III POSEIDON Study

Lung transplantation for acute exacerbation of interstitial lung disease Mwelwa Chizinga, Tiago N Machuca, Abbas Shahmohammadi, Divya C Patel, Ayoub Innabi, Bashar Alzghoul, Vanessa Scheuble, Mauricio Pipkin, Borna Mehrad , Andres Pelaez, Christine Lin, Diana Gomez- Manjarres